|
Supplier News Breaks Archives Finpago Inc. rolled out its EasyCopay automated copayment claims service for pharmacies to all Health Mart members at the McKesson Trade Show in San Francisco. Archimedes Pharma Ltd. and its subsidiary Archimedes Pharma U.S. Inc. have been cleared by the U.S. Food and Drug Administration to market approved Lazanda (fentanyl) nasal spray, for the management of breakthrough pain in cancer patients. Forest Laboratories Inc. has shipped VIIBRYD tablets (vilazodone HCl), an antidepressant, to pharmacies throughout the United States. Head & Shoulders has kicked off "Head & Shoulders Hats Off," a social movement designed to salute Major League Baseball (MLB) teams for their accomplishments on the field. The Federal Trade Commission has reached a settlement requiring Nivea skin cream maker Beiersdorf Inc. to stop claiming that regular use of its Nivea My Silhouette! cream can significantly reduce consumers' body size. Par Pharmaceutical Cos. has restructured its branded drug division, Strativa Pharmaceuticals, as part of a strategic assessment. Eucerin has unveiled the Eucerin Skin Health Cost Calculator, part of the brand's Skin First Movement to educate Americans about the importance of treating their skin care more like health care. Predictors for type 2 diabetes are easily identifiable and may lead to earlier intervention for people at risk, according to a large community study sponsored by AstraZeneca. Skin care is a strong and steady category with room for growth. Qualitest Pharmaceuticals has announced a voluntary nationwide retail-level recall of butalbital, acetaminophen and caffeine tablets (50mg/325mg/40mg) and hydrocodone bitartrate and acetaminophen tablets (7.5mg/500mg). Abbott Diabetes Care is working with the Food and Drug Administration's Office of Criminal Investigations, the Federal Bureau of Investigation and other law enforcement officials to recover a stolen shipment of blood glucose monitoring products.
|
